Altamira TherapeuticsCYTOF
13F holders, Q1 2024 (March 31)3holders
$2.07avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Altamira Therapeutics Ltd. (CYTOF) in their 13F filings. The largest holders were Tower Research Capital LLC (TRC) ($3K), Group One Trading LLC ($29) and LRI Investments, LLC ($2).
- Company
- Altamira Therapeutics Ltd.
- CUSIP
- G0360L134
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $24K |
Ownership 3 holders
| Tower Research Capital LLC (TRC) | 0.00% | Add +95.1% | 1,660 | $3K |
| Group One Trading LLC | 0.00% | No change | 14 | $29 |
| LRI Investments, LLC | 0.00% | — | 1 | $2 |
"% of holder's portfolio" is CYTOF's weight in each manager's 13F, not the share of Altamira Therapeutics Ltd. the manager owns.